LBA2 | ZANUBRUTINIB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS R‐miniCHOP IN UNFIT OR FRAIL PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA AGED 70 YEARS OR OLDER

作者：Peng Xu, Zhenwei Shi, Fei Li, Guifang Ouyang, Zhiming Li, Jing Chen, Jiamin Xu, Rong Li, Yan Xie, Xu Yan, Ou Bai, Hon‐Man Liu, Xiaoning Lu, Wei Zhao, Chuan Wang, Hui Zhou, He Huang, Guangying Cui, Y. Miao, Jingsong He, Dongxu Zhao, Xin Wang, Xin Wang, Hui Lü, J. Zhang, Alex Z. Fu, Hong Li, Meng Sun, Jing Wang, Shih‐Chi Chen, Zhipeng Zhu, Li Wang, Shaochen Cheng, Wei Zhao · 发表于：Hematological Oncology · 年份：2025 · DOI：10.1002/hon.70110_lba2 · 被引用次数：2 · 研究领域：Chronic Lymphocytic Leukemia Research、Viral-associated cancers and disorders、CNS Lymphoma Diagnosis and Treatment